Estimating the Direct Costs of Outpatient Opioid Prescriptions: A Retrospective Analysis of Data from the Rhode Island Prescription Drug Monitoring Program

Journal of Managed Care & Specialty Pharmacy
Hilary ArokeStephen Kogut

Abstract

Overuse and misuse of prescription opioids is associated with increased morbidity and mortality and places a significant cost burden on health systems. To estimate annual statewide spending for prescription opioids in Rhode Island. A cross-sectional study of opioids dispensed from retail pharmacies using data from the Rhode Island Prescription Drug Monitoring Program (PDMP) was performed. The study sample consisted of 651,227 opioid prescriptions dispensed to 197,062 patients between January 1, 2015, and December 31, 2015. The mean, median, and total cost of opioid use was estimated using prescription dispensings and patients as units of analysis. A generalized linear model with gamma distribution with an identity link function, and separately with a log link function, was used to estimate the absolute and relative differences in per-patient annual adjusted average opioid prescription cost, respectively, by potential predictors. The estimated 2015 annual expenditure for opioid prescriptions in Rhode Island was $44,271,827. The average and median costs of an opioid prescription were $67.98 (SD $210.91) and $21.08 (quartile 1 to quartile 3 = $7.65-$47.51), respectively. Prescriptions for branded opioid products accounted for $17,...Continue Reading

References

Apr 1, 1996·Journal of Pain and Symptom Management·R K Portenoy
Jul 21, 1998·JAMA : the Journal of the American Medical Association·O GurejeR Gater
Oct 16, 1999·Lancet·A M ElliottW A Chambers
Feb 7, 2001·JAMA : the Journal of the American Medical Association·D E JoransonJ L Dahl
Jul 27, 2001·Journal of Health Economics·W G Manning, J Mullahy
Nov 15, 2001·Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses·P H Berry, J L Dahl
Oct 29, 2004·Journal of Health Services Research & Policy·Julie Barber, Simon Thompson
Jul 7, 2005·Journal of Managed Care Pharmacy : JMCP·Alan G WhiteNathaniel Katz
Feb 27, 2008·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Emmeline A WatkinsBarbara P Yawn
Jun 25, 2008·The Clinical Journal of Pain·Michael Von KorffConstance Weisner
Jan 19, 2010·Pharmacological Reports : PR·Wojciech Leppert
Nov 19, 2010·The New England Journal of Medicine·Susan Okie
May 12, 2012·Journal of Public Health Dentistry·Heather BeilR Gary Rozier
Aug 4, 2012·Drug and Alcohol Dependence·Jermaine D JonesSandra D Comer
Nov 7, 2012·Journal of Safety Research·Leonard J Paulozzi
Feb 13, 2013·Journal of Clinical Pharmacology·M Soledad CepedaScott C Henderson
Jan 18, 2014·Journal of Pharmacy Practice·Michael JannGaylord Lopez
Feb 24, 2015·Journal of Health Care for the Poor and Underserved·Karin A MackChristopher Jones
Apr 22, 2015·American Journal of Preventive Medicine·Benjamin LevyChristopher M Jones
Oct 16, 2015·MMWR. Surveillance Summaries : Morbidity and Mortality Weekly Report. Surveillance Summaries·Leonard J PaulozziUNKNOWN Centers for Disease Control and Prevention (CDC)
Nov 3, 2015·The American Journal of Medicine·Yong-Fang KuoJames S Goodwin
Dec 24, 2015·Pharmacoepidemiology and Drug Safety·Suzanne NielsenNatasa Gisev
Feb 5, 2016·The New England Journal of Medicine·Robert M CaliffStephen Ostroff
Mar 18, 2016·MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports·Deborah DowellRoger Chou
Dec 30, 2016·MMWR. Morbidity and Mortality Weekly Report·Rose A RuddLawrence Scholl

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.